Early Follicular Phase Human Chorionic Gonadotropin Addition May Improve the Outcomes of In Vitro Fertilization/Intracytoplasmic Sperm Injection in Patients With “Unpredictable” Poor Response to Gonadotropin-Releasing Hormone Antagonist Protocol

PURPOSE: To compare the effects of early and mid-late follicular phase administration of 150 IU of human chorionic gonadotropin (hCG) on gonadotropin-releasing hormone (GnRH) antagonist protocol in “unpredictable” poor ovarian response (POR) women undergoing in vitro fertilization/intracytoplasmic s...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Chunhui, Wu, Fangrong, Wu, Zexuan, Sun, Bolan, Chen, Cheng, Qian, Weiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544820/
https://www.ncbi.nlm.nih.gov/pubmed/34707571
http://dx.doi.org/10.3389/fendo.2021.739773

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544820/
https://www.ncbi.nlm.nih.gov/pubmed/34707571
http://dx.doi.org/10.3389/fendo.2021.739773

Ejemplares similares